Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial

Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial

Abstract Background Within the French-Australian CLL6 RESIDUUM trial, an ancillary study aimed at assessing the health-related quality of life (HRQoL) of patients with chronic lymphocytic leukemia (CLL) receiving a two-year consolidation of lenalidomide (LEN) or observation (OBS) after classical imm...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephane Kroudia Wasse, Sandrine Tienhan Dabakuyo-Yonli, David Gottlieb, Florence Cymbalista, Stephen Mulligan, Marc Maynadie, Thérèse Aurran-Schleinitz
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Chronic lymphocytic leukemia
Health-related quality of life
Patient-reported outcomes
Lenalidomide
Clinical trial
Online Access:https://doi.org/10.1186/s12885-025-13792-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13792-y

Similar Items